INTRODUCTION
Antipsychotics are a group of psychoactive drugs used to treat schizophrenia. The first drugs generation described as typical antipsychotics, such as chlorpromazine, haloperidol (HAL) and sulpiride present main mechanism of action blocking the dopamine D2 receptor. This blockage produces the desired therapeutic effects and side effects, the tardive dyskinesia and catalepsy main drawbacks of this class of drugs (Menegatti et al. 2004 ).
Tardive dyskinesia (TD) is characterized by repetitive, involuntary movements. The most serious aspect of TD is that it may persist for months or years after the drug withdrawal and in some patients are irreversible (Glazer et al. 1990) . Thus, TD has been considered an important clinical problem in the treatment of schizophrenia.
The catalepsy is a typical side effect produced by chronic treatment with neuroleptic. It is characterized by loss of voluntary movement, impaired postural stability, inability to actively initiate movements and persistent abnormal postures. This effect is due to the blockade of D2 receptors at the central level, especially in striatal areas. The catalepsy development occurs after thirty days of treatment with HAL and this effect correlates with reduced locomotor activity.
These effects disappeared after three days of suspension of the drug. After seven days of this suspension, it was observed up-regulation of D2 receptors in the striatum. These phenomena are due to blockade of D2 receptors, though other mechanisms may also be involved (Vasconcelos et al. 2003) . The catalepsy test it is used for an important model for predicting extrapyramidal effects induced by neuroleptics (Chittiprol et al. 2010 ).
D r a f t 4
Evidence suggests that oxidative stress plays an important role in the pathophysiology of TD and catalepsy, a fact proved by studies published about this topic ( Macêdo et al. 2011; Oliveira et al. 2013) . Some of these studies have reported problems with the antioxidant defense and increased lipid peroxidation in animals chronically treated with haloperidol. (Aguiar et al. 2010; Lister et al. 2014; Macêdo et al. 2011; Oliveira et al. 2013 ).
Based on the presence of oxidative stress in the pathophysiological process of TD, studies have been investigating the use of antioxidant therapies in an attempt to minimize extrapyramidal effects produced by chronic use of these typical antipsychotics (Daya et al. 2011; Macêdo et al. 2011; Peroza et al. 2013 ). Among these antioxidant therapies, we can mention the alpha lipoic acid (LA) (Thaakur and Himabindhu 2009) and omega-3 (ω-3) as potent antioxidant (Barcelos et al. 2010 ).
The LA is an antioxidant naturally synthesized in the human body and has been used to treat various diseases when provided as an oral supplement.
Besides acting against free radicals, it promotes the reduction of lipid peroxidation, acts as a cofactor in many enzyme complexes and regenerates damaged tissues Ferreira et al. 2009 ). LA has the ability to combat reactive oxygen species (ROS) both in the lipophilic and hydrophilic environment (Packer et al. 1995) . Due to its powerful antioxidant effect, LA would also be able to prevent neuronal damage caused by ROS produced during neurodegenerative diseases (Araújo et al. 2013 ). In addition, dihydrolipoic acid, the reduced form of the LA, is able to regenerate other antioxidants of low molecular weight, such as glutathione, coenzyme Q10, and vitamins A and C (Packer et al. 1995) . It is also attributed to this substance anti-D r a f t 5 inflammatory activity, and therefore the effect of short-and long-term reduction in oxidative processes related to neurodegenerative diseases. Furthermore, it works as a metal chelator, reducing ROS production (Araújo et al. 2013; Silva et al. 2013 ).
The ω-3 is an essential polyunsaturated fatty acid (PUFA-n3) being acquired from external sources through diet or supplementation (Cardoso 2009).
The ω-3 shows a fundamental role in maintaining neuronal integrity to promote brain development and synaptic plasticity. Besides ω-3 present antioxidant effect by promoting the removal or interfere with the production of ROS (Barcelos et al. 2010) . The EPA and DHA can alter production of catecholamines like dopamine and serotonin, are fundamental for the maintenance of motor function controlled by the dopaminergic system in the corpus striatum (Delattre et al. 2010) .
Considering that oxidative stress is involved in the pathophysiology of dyskinesias induced by chronic use of haloperidol, and the ω-3 (Barcelos et al. 2010 ) and LA (Araújo et al. 2013 ) have antioxidant effects proven in the literature, we hypothesized that the LA and/or ω-3 co-administration could prevent the development of these dyskinesias. Therefore, the aim of this study was to evaluate the behavioral and neurochemical effects of LA and/or ω-3 in HAL-induced TD in rodents. 
DRUGS
Lipoic acid and HAL were purchased from Sigma (USA). ω-3 fish oil EPA-DHA 180/120mg (1000mg) were purchased from TopTherm (Brazil).
EXPERIMENTAL PROTOCOL
The animals were treated with saline (control), LA (100 mg/kg) by The open field tests and catalepsy were performed after 31 days. The orofacial dyskinesia test was performed on 11, 21 and 31 days of treatment. All behavioral tests were performed 1 hour after drug administration. After behavioral tests, the animals will be sacrificed by guillotine, the brain of the animals will be removed and the brain areas of interest (hippocampus -HC; prefrontal cortex -PFC; striatum-S) dissected on ice and stored at -70 C to perform the neurochemical tests (Supplementary Figure S1 ).
ANALYSIS OF MOTOR BEHAVIOR

OPEN-FIELD TEST (OF)
The OF area was made of timber (50 cm × 50 cm × 50 cm) divided into four squares of equal area. The OF was used to evaluate the exploratory activity of the rats. Each rat was placed in the center of the arena and the number of squares crossed, with the four paws (locomotor activity) was recorded for 5 min after a minute of habituation (1 minute). Before introducing each animal, the arena was cleaned with 10% alcohol to eliminate the possible bias due to the odor that could be left by previous animals (Archer 1973) .
CATALEPSY TEST
In this test, front legs of the animals were placed on a rigid bar 2cm thick and 15cm in height. Each rat was placed with its forepaws near the edge of the bar and the amount of time spent in this atypical position was recorded for three times: 60 minutes, 90 minutes and 120 minutes after drug administration. All the rats treated were individually placed on the inclined grid and observed for the 60s (Sanberg et al. 1988 ).
EVALUATION OF DYSKINESIA OROFACIAL
The animals were placed on a scale similar to the open field arena, with mirrors at the base and sides. Thus, the observer had higher viewing angles.
The animals were individually assessed by evaluating the number of vacuous chewing movement and protrusions of the tongue. preparation, they will not be taken into account. The counting is stopped whenever the animal start grooming. The VCM and PT were measured continuously for 6 min after a period of adaptation (6min) (Naidu et al. 2003) .
NEUROCHEMICAL STUDY EVALUATION OF LIPID PEROXIDATION
Brain areas, the PFC, HC and S from all groups were dissected to prepare 10% homogenates (w/v, in 1.15% KCl). The formation of lipid peroxides during lipid peroxidation was followed by measuring the thiobarbituric acid reactive substances (TBARS), as previously described by Draper and Hadley.
Briefly, samples were mixed with 1mL of 10% trichloroacetic acid and 1mL of 0.6% thiobarbituric acid. The reaction media was heated in a boiling water bath for 15 min, and n-butanol (2:1 v/v) was added to the media. After centrifugation (800 ×g, 5min), TBARS contents were determined at 535 nm. The results were expressed as micromoles of malondialdehyde (MDA) per mg protein (Draper and Hadley 1990) .
NITRITE DETERMINATION
Tissue samples from PFC, HC or S were used to prepare 10%
homogenates (w/v). After centrifugation (800 ×g, 10 min), supernatants were collected and the NO production was determined by the Griess reaction. Briefly, 100 ߤL of the supernatant were incubated with 100 ߤL of the Griess reagent [1% sulfanilamide in 1% H 3 PO 4 /0.1% N-(1-naphthyl)-ethylenediamine dihydrochloride/ 1% H 3 PO 4 /distilled water (1:1:1:1)] at room temperature for 10 min. The absorbance was measured at 550 nm microplate reader. Nitrite concentration (ߤM) was determined from a standard NaNO 2 curve (Green 1981 
STATISTICAL ANALYSIS
All tests were analyzed by One-way ANOVA using Prism 5.0 software.
For meaningful results, multiple comparisons were made by the Tukey as the post hoc tests. Results were considered significant at ܲ < 0.05 and presented as mean ± SEM.
RESULTS
BEHAVIORAL TESTS OPEN FIELD TEST
In the open field test, HAL group (0.0±0.0) showed a significant decrease in locomotor activity compared to the control group (41.4±3.9) (p<0.0001). In LA group alone (20.7±2.7) as well as in the ω-3 group alone (25.7±1.6) was observed a decrease in the number of intersections of the quadrants when compared to the control group and increased when compared to the HAL group (p<0.0001)( Figure 1A ).
In the groups of associations with lipoic acid and haloperidol (HAL+ LA:
1.6±1.6) or ω-3 and haloperidol (ω-3+HAL: 8.7±2.0) or lipoic acid, ω-3 and haloperidol group (ω-3+LA+HAL: 11.0±2.9) all showed reduced locomotor activity when compared to control group. However, the latter two groups
showed an increase in locomotor activity when compared with the haloperidol group ( Figure 1A ).
In the evaluation of vertical exploratory activity (rearing) the results to decrease the number of VCM when compared to the group HAL (p<0.0001) (Figure 3 ).
EVALUATION OF OROFACIAL DYSKINESIA
The association group ω-3 and HAL on the eleventh day (5,2±1,4)
showed an increase in the number of VCM compared to the control group 
NEUROCHEMICAL STUDY CONCENTRATION OF LIPID PEROXIDATION (TBARS)
The results showed that chronic exposure of the cells of the PFC, HC and S to HAL (1480±46,7; 1525±69,9; 1522±53,3, respectively) caused an increase in MDA (µmol MDA/g of tissue) content when compared to control group (100,6±22,7, 94,6±20,4, 80,4±7,9, respectively) ( Figure 5A ,B,C).
In the three areas studied the groups treated with LA (PFC: 1041±37,0; (p<0,0001) ( Figure 5A ,B,C).
Also with respect to the associations, the group of ω-3 and HAL presented a greater reduction in MDA levels when compared to the combination of LA and HAL group in the PFC and HC (Fig. 5-A,B) . In contrast, the association group with LA, ω-3 and HAL showed better response in the reduction of lipid peroxidation induced by chronic use of HAL presenting results close to those obtained in the control group in the three areas studied (ω-3+LA+HAL PFC: 211,1±44,0, HC: 101,1±38,9, S: 121,9±43,2) ( Figure 5A ,B,C).
NITRITE DETERMINATION
The results showed that the concentrations of nitrite/nitrate (µmol/g of tissue) in the HAL group (2,8±0,0) increased in the PFC group compared to the control group (1,0±0,0). The group of LA alone (1,9±0,1) or ω-3 alone (1,8±0,0)
showed an increase in the concentrations of nitrite/nitrate compared to the control group in the PFC and a decrease when compared to the HAL group ( Figure 6A ). 
DISCUSSION
The open field test aims to study the action of the dopamine system, serotonergic and noradrenergic emotional and exploratory behavior through the horizontal scanning (mobility), vertical (rearing) and self-cleaning (grooming). It is widely used as an evaluation tool of the substances action that may act on these neurotransmitter systems promoting motor abnormalities (bradykinesia or hyperlocomotion) and emotional (anxiety) (Schallert 2000) .
The results showed that LA and ω-3 promoted improvement in motor
performance in the open field test. This improves motor due to the antioxidant D r a f t 14 effect of these substances, reflecting on monoamines levels. The LA has the capacity to alter the levels of monoamines and their metabolites by stimulating the synthesis, release in the synaptic cleft and reduced metabolism of these neurotransmitters thereby increasing its availability in the CNS (Chang et al. 2009; Santos et al. 2010 ).
The LA and ω 3 they were able to reduce the time spent in the bar in the catalepsy test, indicating a possible neuroprotective effect. This effect is related to the ability of these substances has to control the state oxidant / antioxidant, stabilizing the membranes of brain tissue structures and acting as antiapoptotic (Barcelos et al. 2010; Thaakur et al. 2009 ). This effect is due to the reduction in ROS levels as well as increased content of SOD, CAT, and GHP. Studies have shown that the D2 receptor blockade is related to the increase in glutamate release in the striatum, it produces such an increase resulting in a chronic neurotoxicity extrapyramidal events resulting from chronic use of such antipsychotics (Bošković et al. 2013; Naidu et al. 2003; Thaakur et al. 2009 ).
D r a f t 15
The nervous system is more sensitive to the damaging action of free radicals than other tissues of the organism once the metabolism of the brain is extremely high which favors the continual formation of reactive oxygen species and nitrogen, addition of the antioxidant defense system not be as effective in removing these agents, thus favoring neurodegeneration (Ferreira et al. 2016 ).
Evidence suggests that oxidative stress plays an important role in the pathophysiology of TD, a fact proven by studies published about this topic (Aguiar et al. 2010; Oliveira et al. 2013) .
In this research, the HAL increased the concentration of nitrite/nitrate in the striatum. Another interesting result is that oxidative damage was not restricted to this area of the brain, but also mostly affected the prefrontal cortex and hippocampus. This demonstrates that the changes produced by chronic use of HAL are not limited only to the neurons of the striatum.
As an antioxidant LA and ω-3 work removing the hydroxyl radicals, hydrogen peroxide in its free form, superoxide and peroxynitrite (Araújo et al 2011; Bošković et al. 2016 ). Because of this potent effect LA and ω-3, would also be able to prevent neuronal damage caused by reactive species derived from oxygen and nitrogen (Bošković et al. 2016; Maczurek et al. 2008; Thaakur et al. 2009 ).
The omega-3 plays a fundamental role in maintaining neuronal integrity to promote brain development and synaptic plasticity. Besides ω-3 present a possible antioxidant effect by promoting the removal or interfere with the production of ROS. The EPA and DHA can alter production of catecholamines like dopamine and serotonin, are fundamental for the maintenance of motor function controlled by the dopaminergic system in the striatum (Cardoso 2009).
D r a f t
Lipid peroxidation is the broader process of oxidative damage by promoting the breakdown of the cell membrane lipids and the formation of the peroxyl radical. Once started the event, this spreads inducing cell destruction chain (Ferreira et al. 2016 ).
LA and ω-3 showed a possible neuroprotective effect since it was able to significantly reduce the lipid peroxidation in the TBARS assay in the striatum and prefrontal cortex and hippocampus.
The EPA and DHA to be metabolized by cyclooxygenase-2 (COX-2) resolvin produce the E and D series, respectively. The DHA can be converted to protectine D1 and D1 neuroprotectine by the action of lipoxygenase (LOX). The neuroprotectine D1 is produced in response to oxidative damage in the brain, serving as antiinflammatory and antioxidant (Cardoso 2009).
CONCLUSION
The LA and the ω-3 were able to promote an improvement of motor 80x243mm (300 x 300 DPI)
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